| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848273 | American Journal of Kidney Diseases | 2013 | 12 Pages |
Abstract
The therapeutic approach in fibrillary GN remains challenging. The place of immunosuppressive therapy, particularly anti-B-cell agents, needs to be assessed in larger collaborative studies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Vincent MD, Alexandre MD, François MD, Brigitte MD, Corinne Lacombe, Jean-Michel MD, PhD, Stéphanie PharmD, PhD, Pierre PhD, Guy MD, Frank MD, PhD,